UK ' s MHRA Revokes Authorisation for Novartis ' Sickle Cell Drug UK ' s MHRA Revokes Authorisation for Novartis ' Sickle Cell Drug

Britain ' s health regulator said on Wednesday it had revoked a conditional marketing authorisation for Novartis ' sickle cell disease drug, Adakveo.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care Source Type: news